UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

cMET inhibition potentiates the tumor‐selective damaging effects of NQO1‐bioactivatable agents by compromising DNA repair

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

HGFA Is an Injury-Regulated Systemic Factor that Induces the Transition of Stem Cells into GAlert

Cell reports (Cambridge), 2017-04, Vol.19 (3), p.479-486

2017

Volltextzugriff (PDF)

Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway

Gene, 2020-09, Vol.754, p.144811-144811, Article 144811

2020

Volltextzugriff (PDF)

A Phase 1 Study of Cabozantinib and Trifluridine/Tipiracil in Metastatic Colorectal Adenocarcinoma

Clinical colorectal cancer, 2024-03, Vol.23 (1), p.67-72

2024

Volltextzugriff (PDF)

MiRNA-206 inhibits hepatocellular carcinoma cell proliferation and migration but promotes apoptosis by modulating cMET expression

Acta biochimica et biophysica Sinica, 2019-03, Vol.51 (3), p.243-253

2019

Volltextzugriff (PDF)

Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells

Phytomedicine (Stuttgart), 2023-08, Vol.117, p.154914-154914, Article 154914

2023

Volltextzugriff (PDF)

Matrix metalloproteinase 2 is a target of the RAN-GTP pathway and mediates migration, invasion and metastasis in human breast cancer

Life sciences (1973), 2022-12, Vol.310, p.121046-121046, Article 121046

2022

Volltextzugriff (PDF)

Acquisition of chromosome instability is a mechanism to evade oncogene addiction

EMBO molecular medicine, 2020-03, Vol.12 (3), p.e10941-n/a

2020

Volltextzugriff (PDF)

Urinary cMet as a prognostic marker in immunoglobulin A nephropathy

Journal of cellular and molecular medicine, 2020-10, Vol.24 (19), p.11158-11169

2020

Volltextzugriff (PDF)

Bushen Huoxue recipe ameliorates ovarian function via promoting BMSCs proliferation and homing to ovaries in POI mice

Phytomedicine (Stuttgart), 2024-07, Vol.129, p.155630-155630, Article 155630

2024

Volltextzugriff (PDF)

Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET Inhibitors

ACS medicinal chemistry letters, 2019-09, Vol.10 (9), p.1322-1327

2019

Volltextzugriff (PDF)

Associations between adherence to 24-Hour Movement Guidelines with continuous metabolic syndrome score among Chinese children and adolescents

Public health (London), 2024-11, Vol.236, p.274-280

2024

Volltextzugriff (PDF)

Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancers

Annals of diagnostic pathology, 2018-08, Vol.35, p.69-76

2018

Volltextzugriff (PDF)

Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models

Proceedings of the National Academy of Sciences - PNAS, 2018-02, Vol.115 (9), p.E2077-E2084

2018

Volltextzugriff (PDF)

Structure based designing of triazolopyrimidone-based reversible inhibitors for kinases involved in NSCLC

Bioorganic & medicinal chemistry letters, 2019-07, Vol.29 (13), p.1565-1571

2019

Volltextzugriff (PDF)

Targeting the cMET pathway to enhance immunotherapeutic approaches for mUM patients

Frontiers in oncology, 2023-01, Vol.12, p.1068029-1068029

2023

Volltextzugriff (PDF)

Roles of MET in Cancer Development and Treatment

2023

Volltextzugriff (PDF)

Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer

Lung cancer (Amsterdam, Netherlands), 2020-02, Vol.140, p.46-54

2020

Volltextzugriff (PDF)

cMET Exon 14 Skipping: From the Structure to the Clinic

Journal of thoracic oncology, 2016-09, Vol.11 (9), p.1423-1432

2016

Volltextzugriff (PDF)

Low co-expression of PD-L1 and oncogenic receptor tyrosine kinases HER2 and cMET in urothelial carcinoma is associated with discordant expression between primary and metastatic sites

Urologic oncology, 2023-08, Vol.41 (8), p.357.e23-357.e29

2023

Volltextzugriff (PDF)

Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations

International journal of molecular sciences, 2023-08, Vol.24 (16), p.12840

2023

Volltextzugriff (PDF)

Precision immunotherapy for cholangiocarcinoma: Pioneering the use of human-derived anti-cMET single chain variable fragment in anti-cMET chimeric antigen receptor (CAR) NK cells

International immunopharmacology, 2024-07, Vol.136, p.112273, Article 112273

2024

Volltextzugriff (PDF)

Overexpression of Hepatocyte growth factor and its soluble receptor (s-cMet) in the serum of patients with different grades of meningioma

Journal of clinical neuroscience, 2021-11, Vol.93, p.1-5

2021

Volltextzugriff (PDF)

HGF Mediates Clinical‐Grade Human Umbilical Cord‐Derived Mesenchymal Stem Cells Improved Functional Recovery in a Senescence‐Accelerated Mouse Model of Alzheimer's Disease

Advanced science, 2020-09, Vol.7 (17), p.1903809-n/a

2020

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(131)

Publikationsform

Sprache

Englisch
(145)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(126)
Life Sciences & Biomedicine
(120)
Cmet
(101)
Humans
(80)
Oncology
(52)
Female
(37)
Proto-Oncogene Proteins C-Met - Metabolism
(34)
Animals
(29)
Tumors
(27)
Male
(26)
Cell Line, Tumor
(24)
Kinases
(24)
Middle Aged
(23)
Hepatocyte Growth Factor
(22)
Pharmacology & Pharmacy
(21)
Mutation
(20)
Proto-Oncogene Proteins C-Met - Genetics
(20)
Prognosis
(19)
Egfr
(18)
Aged
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

cMET inhibition potentiates the tumor‐selective damaging effects of NQO1‐bioactivatable agents by compromising DNA repair

HGFA Is an Injury-Regulated Systemic Factor that Induces the Transition of Stem Cells into GAlert

Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway

A Phase 1 Study of Cabozantinib and Trifluridine/Tipiracil in Metastatic Colorectal Adenocarcinoma

MiRNA-206 inhibits hepatocellular carcinoma cell proliferation and migration but promotes apoptosis by modulating cMET expression

Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells

Matrix metalloproteinase 2 is a target of the RAN-GTP pathway and mediates migration, invasion and metastasis in human breast cancer

Acquisition of chromosome instability is a mechanism to evade oncogene addiction

Urinary cMet as a prognostic marker in immunoglobulin A nephropathy

Bushen Huoxue recipe ameliorates ovarian function via promoting BMSCs proliferation and homing to ovaries in POI mice

Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET Inhibitors

Associations between adherence to 24-Hour Movement Guidelines with continuous metabolic syndrome score among Chinese children and adolescents

Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancers

Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models

Structure based designing of triazolopyrimidone-based reversible inhibitors for kinases involved in NSCLC

Targeting the cMET pathway to enhance immunotherapeutic approaches for mUM patients

Roles of MET in Cancer Development and Treatment

Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer

cMET Exon 14 Skipping: From the Structure to the Clinic

Low co-expression of PD-L1 and oncogenic receptor tyrosine kinases HER2 and cMET in urothelial carcinoma is associated with discordant expression between primary and metastatic sites

Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations

Precision immunotherapy for cholangiocarcinoma: Pioneering the use of human-derived anti-cMET single chain variable fragment in anti-cMET chimeric antigen receptor (CAR) NK cells

Overexpression of Hepatocyte growth factor and its soluble receptor (s-cMet) in the serum of patients with different grades of meningioma

cMET: a prognostic marker in papillary renal cell carcinoma?

HGF Mediates Clinical‐Grade Human Umbilical Cord‐Derived Mesenchymal Stem Cells Improved Functional Recovery in a Senescence‐Accelerated Mouse Model of Alzheimer's Disease

Suchergebnisse filtern